Akebia Therapeutics Inc

Business Description

Akebia Therapeutics is a Cambridge, Massachusetts-based company founded in 2007 that develops and sells treatments for people living with kidney disease. Its two main products are Vafseo, a pill taken by dialysis and non-dialysis patients to treat anemia caused by chronic kidney disease, and Auryxia, which helps manage phosphorus levels and iron deficiency anemia in similar patient groups. The company also has earlier-stage treatments in development targeting kidney injury following heart surgery and a vision condition in premature newborns. Akebia works with several partners around the world, including Tanabe Pharma Corporation, which holds rights to commercialize Vafseo across Japan and parts of Asia.